420 related articles for article (PubMed ID: 16022816)
1. [Drug-eluting stents and other anti-restenosis devices].
Moreno R
Rev Esp Cardiol; 2005 Jul; 58(7):842-62. PubMed ID: 16022816
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting stent: the emerging technique for the prevention of restenosis.
Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting stents: from randomized trials to the real world.
Saia F; Degertekin M; Lemos PA; Serruys PW
Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
5. Which parameter should be chosen as primary endpoint for randomized drug-eluting stent studies?
Silber S
J Interv Cardiol; 2004 Dec; 17(6):375-85. PubMed ID: 15546289
[TBL] [Abstract][Full Text] [Related]
6. Drug-eluting stents: preventing restenosis.
Slavin L; Chhabra A; Tobis JM
Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting stents.
Chieffo A; Colombo A
Minerva Cardioangiol; 2002 Oct; 50(5):419-29. PubMed ID: 12384624
[TBL] [Abstract][Full Text] [Related]
8. Treatment of restenosis after bare-metal and drug-eluting stenting of an aorto-ostial lesion: challenges associated with excessive stent overhang.
Kunadian B; Vijayalakshmi K; de Belder MA
J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):744-7. PubMed ID: 17700411
[TBL] [Abstract][Full Text] [Related]
9. [Drug-eluting stents do they make the difference? ].
Presbitero P; Asioli M
Minerva Cardioangiol; 2002 Oct; 50(5):431-42. PubMed ID: 12384625
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting stents: the panacea for restenosis?
Lim MC
Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
[No Abstract] [Full Text] [Related]
11. [Restenosis inside the stent: treatment and prevention].
Arablinskiĭ AV; Zakharova OV; Kononov AV
Klin Med (Mosk); 2004; 82(9):10-3. PubMed ID: 15540414
[No Abstract] [Full Text] [Related]
12. Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials.
Halkin A; Stone GW
J Interv Cardiol; 2004 Oct; 17(5):271-82. PubMed ID: 15491330
[TBL] [Abstract][Full Text] [Related]
13. Coronary restenosis after implantation of drug-eluting stents.
Schofer J; Schlüter M
Minerva Cardioangiol; 2005 Feb; 53(1):43-8. PubMed ID: 15788978
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.
Dibra A; Kastrati A; Alfonso F; Seyfarth M; Pérez-Vizcayno MJ; Mehilli J; Schömig A
J Am Coll Cardiol; 2007 Feb; 49(5):616-23. PubMed ID: 17276188
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
[TBL] [Abstract][Full Text] [Related]
17. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
Er F; Erdmann E
Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies.
Schofer J; Bode C; Silber S
Herz; 2004 Mar; 29(2):195-200. PubMed ID: 15057441
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
20. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
Ray GM; Nawarskas JJ; Frishman WH
Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
